Commentary on “New Challenges for Public Health Care: Biological and Chemical Weapons Awareness,Surveillance,and Response”

Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, and others. 2001. Botulinum toxin as a biological weapon: medical and public health management. J Am Med Assoc 285: 1059-70.

Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, Ksiazek T, Johnson KM, Meyerhoff A, O’Toole T, and others. 2002. Hemorrhagic fever viruses as biological weapons: medical and public health management. J Am Med Assoc 287: 2391-405.

Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, and others. 2001. Tularemia as a biological weapon: medical and public health management. J Am Med Assoc 285: 2763-73.

Glass T, Schoch-Spana M. 2002. Bioterrorism and the public: how to vaccinate a city against panic. Clin Infectious Diseases 34: 217-23.

Henderson DA. 1999. The looming threat of bioterrorism. Science 283: 1279-82.

Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, and others. 1999. Smallpox as a biological weapon: medical and public health management. J Am Med Assoc 281: 2127-37.

Inglesby TV. 2002. Congressional testimony, the state of public health preparedness for terrorism involving weapons of mass destruction—a six month report card. U.S. Senate Committee on Government Affairs. Available from: http://www.hopkins-biodefense.org/pages/resources/tom.html. Accessed 2003 Jan 15.

Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, and others. 2000a. Plague as a biological weapon: medical and public health management. J Am Med Assoc 283: 2281-90.

Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Hauer J, McDade J, Osterholm MT, O’Toole T, and others. 1999. Anthrax as a biological weapon: medical and public health management. J Am Med Assoc 281: 1735-45.

Inglesby TV, O’Toole T, Henderson, DA. 2000b. Addressing the challenge of biological weapons. Clin Infectious Diseases 30: 926-9.

Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, and others. 2002. Anthrax as a biological weapon, 2002: updated recommendations for management. J Am Med Assoc 287: 2236-52.

O’Toole T. 1999. Congressional testimony, hearing on terrorism preparedness: medical first response. House of Representatives Committee on Government Reform, Subcommittee on National Security, Veteran Affairs, and International Relations. Available from: http://www.hopkins-biodefense.org/pages/resources/prepare.html. Accessed 2003 Jan 15.

O’Toole T. 2001. Congressional testimony, terrorism through the mail: protecting postal workers and the public (part II). U.S. Senate Committee on Government Affairs, Subcommittee on International Security, Proliferation and Federal Services. Available from: http://www.hopkins-biodefense.org/pages/resources/otoole.html. Accessed 2003 Jan 15.

O’Toole T, Inglesby TV, Schoch-Spana M. 2000. Bioterrorism: national security threat, public health emergency. Unpublished manuscript.

Radonovich, L. 2002. Hopkins center to launch clinicians’ biodefense network. Biodefense Quarterly [serial online]; 4: 1-2, 11. Available from: http://www.hopkins-biodefense.org/pages/news/pdf/quarter4_2.pdf. Accessed 2003 Jan 15.

Smithson AE, Levy LA. 2000. Ataxia: the chemical and biological terrorism threat and the U.S. response. Washington (DC): Henry L. Stimson Center.

Tucker JB. 1997. National health and medical services response to incidents of chemical and biological terrorism. J Am Med Assoc 278: 362-8.

Ursano B, Fullerton, CS, Norwood AE, editors. 2002. Responding to bioterrorism: individual and community needs. Bethesda (MD): Center for the Study of Traumatic Stress, Department of Psychiatry, Uniformed Services University of the Health Sciences.